Organogenesis Holdings (ORGO) Change in Accured Expenses (2016 - 2026)

Organogenesis Holdings' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $293000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 103.67% year-over-year to $293000.0; the TTM figure through Mar 2026 stood at $18.7 million (up 198.02% YoY), while the FY2025 annual figure was $10.4 million, up 1077.5% from the prior year.
• Change in Accured Expenses was $293000.0 for Q1 2026 at Organogenesis Holdings, down from $12.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $12.3 million in Q4 2025 to a low of -$8.0 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $754235.3 across 5 years, with a median of -$938000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses plunged 371.3% in 2022, then soared 623.82% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $4.1 million in 2022, then sank by 221.97% to -$5.0 million in 2023, then slumped by 37.75% to -$6.9 million in 2024, then jumped by 277.48% to $12.3 million in 2025, then slumped by 97.62% to $293000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $293000.0 (Q1 2026), $12.3 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.